Electroconvulsive Therapy for Parkinson's Disease: A Systematic Review and Meta‐Analysis
Sign Up to like & getrecommendations! Published in 2020 at "Movement Disorders"
DOI: 10.1002/mds.28335
Abstract: Electroconvulsive therapy (ECT) is a well‐established treatment for psychiatric disorders, including depression and psychosis. ECT has been reported to be effective in treating such psychiatric symptoms in patients with Parkinson's disease (PD) and has been… read more here.
Keywords: therapy parkinson; disease systematic; electroconvulsive therapy; parkinson disease ... See more keywords
Opicapone: once‐daily adjunctive therapy for Parkinson's disease
Sign Up to like & getrecommendations! Published in 2017 at "Prescriber"
DOI: 10.1002/psb.1543
Abstract: Opicapone (Ongentys) is a new once‐daily catechol‐O‐methyl transferase (COMT) inhibitor with a long duration of action allowing once‐daily dosing, licensed for adjunctive therapy in adults with Parkinson's disease and end‐of‐dose motor fluctuations. This article discusses… read more here.
Keywords: adjunctive therapy; opicapone daily; parkinson disease; therapy parkinson ... See more keywords
Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson's Disease: Online-Based Delphi Survey
Sign Up to like & getrecommendations! Published in 2022 at "Parkinson's Disease"
DOI: 10.1155/2022/3203212
Abstract: Background Safinamide is a selective, reversible monoamine oxidase-B inhibitor with a sodium channel inhibitory effect. Published clinical evidence supports safinamide as an effective therapy for Parkinson's disease (PD) with wearing-off. However, to date, no consensus… read more here.
Keywords: parkinson disease; use safinamide; expert perspectives; perspectives use ... See more keywords
Bilirubin: A Promising Therapy for Parkinson’s Disease
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22126223
Abstract: Following the increase in life expectancy, the prevalence of Parkinson’s disease (PD) as the most common movement disorder is expected to rise. Despite the incredibly huge efforts in research to find the definitive biomarker, to… read more here.
Keywords: promising therapy; bilirubin promising; disease; parkinson disease ... See more keywords